midazolam has been researched along with transforming growth factor beta in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Babcock, GF; Dugan, A; Hernandez, L; Schwemberger, S; Yadav, E | 1 |
Chen, YC; Huang, BM; So, EC; Wang, YK; Wu, KC | 1 |
2 other study(ies) available for midazolam and transforming growth factor beta
Article | Year |
---|---|
The burn wound inflammatory response is influenced by midazolam.
Topics: Animals; Burns; Chemokine CCL2; Chemokine CCL3; Chemokine CCL4; Chemokine CXCL2; Inflammation; Interleukin-10; Interleukin-1beta; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Midazolam; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; RNA, Messenger; Skin; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Wound Healing | 2012 |
Midazolam inhibits chondrogenesis via peripheral benzodiazepine receptor in human mesenchymal stem cells.
Topics: Cell Differentiation; Cell Line; Chondrogenesis; GABA-A Receptor Antagonists; Humans; Isoquinolines; Mesenchymal Stem Cells; Midazolam; Phosphorylation; Receptors, GABA-A; Smad3 Protein; Transforming Growth Factor beta | 2018 |